Matinas BioPharma (MTNB)
NYSE MKT:MTNB
Holding MTNB?
Track your performance easily

Matinas BioPharma (MTNB) Financial Statements

1,512 Followers

Matinas BioPharma Financial Overview

Matinas BioPharma's market cap is currently ―. The company's EPS TTM is $-5.103; its P/E ratio is -0.11; Matinas BioPharma is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-1.05. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.72M$ 5.98M$ -5.31M$ -6.05M$ -6.06M
EBITDA$ -5.51M$ 6.24M$ -5.06M$ -5.80M$ -5.80M
Net Income Common Stockholders$ -5.72M$ -5.82M$ -5.31M$ -6.05M$ -6.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 14.31M$ 8.11M$ 13.76M$ 18.22M$ 22.56M
Total Assets$ 24.36M$ 19.61M$ 25.10M$ 29.79M$ 34.02M
Total Debt$ 3.24M$ 3.40M$ 3.56M$ 3.71M$ 3.85M
Net Debt$ -11.07M$ -4.71M$ -10.20M$ -14.51M$ -18.71M
Total Liabilities$ 5.26M$ 5.05M$ 5.86M$ 6.64M$ 6.17M
Stockholders Equity$ 19.10M$ 14.56M$ 19.25M$ 23.15M$ 27.85M
Cash Flow-
Free Cash Flow$ -3.11M$ -5.77M$ -4.58M$ -4.43M$ -2.40M
Operating Cash Flow$ -3.11M$ -5.77M$ -4.58M$ -4.42M$ -2.19M
Investing Cash Flow$ -2.94M$ 2.00M$ 2.96M$ 1.08M$ 6.20M
Financing Cash Flow$ 9.19M$ 53.00K$ -1.00K$ -1.00K$ -1.00K
Currency in USD

Matinas BioPharma Earnings and Revenue History

Matinas BioPharma Debt to Assets

Matinas BioPharma Cash Flow

Matinas BioPharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis